Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68

Benzinga · 2d ago
Citizens analyst Daniel Stauder maintains AtriCure (NASDAQ:ATRC) with a Market Outperform and raises the price target from $52 to $68.